Femtoliter droplet confinement of Streptococcus pneumoniae: bacterial genetic transformation by cell-cell interaction in droplets.
Anti-Bacterial Agents
/ pharmacology
Cell Communication
/ drug effects
Cells, Cultured
DNA, Bacterial
/ drug effects
Drug Resistance, Microbial
/ drug effects
Microbial Sensitivity Tests
Microfluidic Analytical Techniques
/ instrumentation
Novobiocin
/ pharmacology
Particle Size
Rifampin
/ pharmacology
Spectinomycin
/ pharmacology
Streptococcus pneumoniae
/ cytology
Surface Properties
Transformation, Bacterial
/ drug effects
Journal
Lab on a chip
ISSN: 1473-0189
Titre abrégé: Lab Chip
Pays: England
ID NLM: 101128948
Informations de publication
Date de publication:
12 02 2019
12 02 2019
Historique:
pubmed:
19
1
2019
medline:
7
9
2019
entrez:
19
1
2019
Statut:
ppublish
Résumé
Streptococcus pneumoniae (pneumococcus), a deadly bacterial human pathogen, uses genetic transformation to gain antibiotic resistance. Genetic transformation begins when a pneumococcal strain in a transient specialized physiological state called competence, attacks and lyses another strain, releasing DNA, taking up fragments of the liberated DNA, and integrating divergent genes into its genome. While many steps of the process are known and generally understood, the precise mechanism of this natural genetic transformation is not fully understood and the current standard strategies to study it have limitations in specifically controlling and observing the process in detail. To overcome these limitations, we have developed a droplet microfluidic system for isolating individual episodes of bacterial transformation between two confined cells of pneumococcus. By encapsulating the cells in a 10 μm diameter aqueous droplet, we provide an improved experimental model of genetic transformation, as both participating cells can be identified, and the released DNA is spatially restricted near the attacking strain. Specifically, the bacterial cells, one rifampicin (R) resistant, the other novobiocin (N) and spectinomycin (S) resistant were encapsulated in droplets carried by the fluorinated oil FC-40 with 5% surfactant and allowed to carry out competence-specific attack and DNA uptake (and consequently gain antibiotic resistances) within the droplets. The droplets were then broken, and recombinants were recovered by selective plating with antibiotics. The new droplet system encapsulated 2 or more cells in a droplet with a probability up to 71%, supporting gene transfer rates comparable to standard mixtures of unconfined cells. Thus, confinement in droplets allows characterization of natural genetic transformation during a strictly defined interaction between two confined cells.
Identifiants
pubmed: 30657515
doi: 10.1039/c8lc01367e
pmc: PMC6487891
mid: NIHMS1007689
doi:
Substances chimiques
Anti-Bacterial Agents
0
DNA, Bacterial
0
Novobiocin
17EC19951N
Spectinomycin
93AKI1U6QF
Rifampin
VJT6J7R4TR
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
682-692Subventions
Organisme : NIAID NIH HHS
ID : R21 AI133304
Pays : United States
Références
Phys Rev Lett. 2001 Apr 30;86(18):4163-6
pubmed: 11328121
Phys Rev Lett. 2001 Dec 31;87(27 Pt 1):274501
pubmed: 11800883
Proc Natl Acad Sci U S A. 2002 May 28;99(11):7681-6
pubmed: 12032343
Front Biosci. 2002 Aug 01;7:d1798-814
pubmed: 12133809
Angew Chem Int Ed Engl. 2003 Feb 17;42(7):768-72
pubmed: 12596195
Antimicrob Agents Chemother. 2003 Mar;47(3):863-8
pubmed: 12604513
Phys Rev Lett. 2003 Apr 11;90(14):144505
pubmed: 12731923
J Mol Biol. 1962 Jul;5:119-31
pubmed: 14461406
J Bacteriol. 2003 Dec;185(24):7176-83
pubmed: 14645278
Mol Microbiol. 2004 Feb;51(4):1051-70
pubmed: 14763980
Lab Chip. 2002 Feb;2(1):24-6
pubmed: 15100856
J Bacteriol. 2004 May;186(10):3078-85
pubmed: 15126469
Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8710-5
pubmed: 15928084
J Microbiol Methods. 2005 Aug;62(2):181-97
pubmed: 16009276
Electrophoresis. 2005 Oct;26(19):3716-24
pubmed: 16196106
Mol Microbiol. 2006 Feb;59(4):1297-307
pubmed: 16430701
Lab Chip. 2006 Mar;6(3):437-46
pubmed: 16511628
Antimicrob Agents Chemother. 2006 Apr;50(4):1228-37
pubmed: 16569833
Proc Natl Acad Sci U S A. 1954 Feb;40(2):49-55
pubmed: 16589433
Nat Rev Microbiol. 2007 Mar;5(3):219-29
pubmed: 17277796
Chem Biol. 2008 May;15(5):427-37
pubmed: 18482695
Mol Microbiol. 2008 Jul;69(1):245-53
pubmed: 18485065
Lab Chip. 2008 Aug;8(8):1265-72
pubmed: 18651067
J Bacteriol. 2009 May;191(10):3359-66
pubmed: 19286798
Microbiology. 2009 Jul;155(Pt 7):2223-34
pubmed: 19389766
Angew Chem Int Ed Engl. 2009;48(32):5908-11
pubmed: 19565587
Lancet. 2009 Sep 12;374(9693):893-902
pubmed: 19748398
Phys Rev E Stat Nonlin Soft Matter Phys. 2009 Aug;80(2 Pt 2):026310
pubmed: 19792252
J Exp Med. 1944 Feb 1;79(2):137-58
pubmed: 19871359
J Mol Med (Berl). 2010 Feb;88(2):97-102
pubmed: 19898768
Nat Protoc. 2010 Mar;5(3):491-502
pubmed: 20203666
J Hyg (Lond). 1928 Jan;27(2):113-59
pubmed: 20474956
ACS Chem Biol. 2011 Mar 18;6(3):260-6
pubmed: 21142208
Anal Chem. 1998 Dec 1;70(23):4974-84
pubmed: 21644679
PLoS Pathog. 2011 Aug;7(8):e1002190
pubmed: 21829369
Lab Chip. 2012 Feb 7;12(3):422-33
pubmed: 22011791
PLoS Pathog. 2012;8(6):e1002745
pubmed: 22719250
Expert Rev Vaccines. 2012 Jul;11(7):841-55
pubmed: 22913260
Nat Protoc. 2013 May;8(5):870-91
pubmed: 23558786
PLoS One. 2013 May 22;8(5):e64197
pubmed: 23717566
Sci Rep. 2013 Dec 10;3:3462
pubmed: 24322507
Trends Microbiol. 2014 Mar;22(3):113-9
pubmed: 24508048
ACS Nano. 2014 Apr 22;8(4):3913-20
pubmed: 24646088
Cell. 2014 Apr 10;157(2):395-406
pubmed: 24725406
Comput Struct Biotechnol J. 2015 Apr 08;13:241-7
pubmed: 25904996
Lab Chip. 2015 Sep 7;15(17):3439-59
pubmed: 26226550
J Bacteriol. 2016 Aug 11;198(17):2370-8
pubmed: 27353650
Angew Chem Int Ed Engl. 1998 Mar 16;37(5):550-575
pubmed: 29711088
PLoS Genet. 2018 Jun 13;14(6):e1007410
pubmed: 29897968
Methods Enzymol. 1979;68:326-31
pubmed: 396437
Biochim Biophys Acta. 1973 Apr 11;299(4):545-56
pubmed: 4145314
Antimicrob Agents Chemother. 1972 Dec;2(6):427-30
pubmed: 4274968
J Mol Biol. 1968 Feb 28;32(1):83-100
pubmed: 4384454
Infect Immun. 1980 Feb;27(2):444-8
pubmed: 6991416
Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11140-4
pubmed: 7479953
N Engl J Med. 1995 Aug 24;333(8):481-6
pubmed: 7623880
J Clin Microbiol. 1995 Jul;33(7):1720-6
pubmed: 7665635
J Bacteriol. 1996 Oct;178(20):6087-90
pubmed: 8830714
Pediatr Infect Dis J. 1996 Oct;15(10):932-4
pubmed: 8895937
Microb Drug Resist. 1997 Spring;3(1):27-37
pubmed: 9109094
Clin Infect Dis. 1997 Jun;24(6):1052-9
pubmed: 9195057
Antimicrob Agents Chemother. 1976 Aug;10(2):274-6
pubmed: 984768